Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$4.8 - $11.6 $6,240 - $15,080
-1,300 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$9.05 - $10.95 $13,575 - $16,425
-1,500 Reduced 53.57%
1,300 $12,000
Q2 2018

Aug 14, 2018

BUY
$10.2 - $13.9 $28,559 - $38,920
2,800 New
2,800 $28,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.